David Plouffe

CIK: 0001844229

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)9 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OSCR

Oscar Health, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

OSCR
Oscar Health, Inc.
Oct 8, 2026
Award(A)
Deferred Stock Unit
Direct
641 shares at avg. $33.10-
OSCR
Oscar Health, Inc.
Jul 9, 2026
Award(A)
Deferred Stock Unit
Direct
681 shares at avg. $31.20-
OSCR
Oscar Health, Inc.
Jun 4, 2026
Award(A)
Direct
8.5K shares-
OSCR
Oscar Health, Inc.
Apr 9, 2026
Award(A)
Deferred Stock Unit
Direct
1.5K shares at avg. $14.54-
OSCR
Oscar Health, Inc.
Jan 8, 2026
Award(A)
Deferred Stock Unit
Direct
1.3K shares at avg. $16.90-
OSCR
Oscar Health, Inc.
Oct 9, 2025
Award(A)
Deferred Stock Unit
Direct
1K shares at avg. $20.54-
OSCR
Oscar Health, Inc.
Jul 10, 2025
Award(A)
Deferred Stock Unit
Direct
1.4K shares at avg. $15.53-
OSCR
Oscar Health, Inc.
Jun 4, 2025
Award(A)
Direct
14.1K shares-
OSCR
Oscar Health, Inc.
Apr 10, 2025
Award(A)
Deferred Stock Unit
Direct
1.7K shares at avg. $12.25-

		Type	Shares	Price		Ownership
Oct 8, 2026	OSCR Oscar Health, Inc.	Award(A) Deferred Stock Unit	641	$33.10	-	Direct
Jul 9, 2026	OSCR Oscar Health, Inc.	Award(A) Deferred Stock Unit	681	$31.20	-	Direct
Jun 4, 2026	OSCR Oscar Health, Inc.	Award(A)	8,475	-	$0	Direct
Apr 9, 2026	OSCR Oscar Health, Inc.	Award(A) Deferred Stock Unit	1,461	$14.54	-	Direct
Jan 8, 2026	OSCR Oscar Health, Inc.	Award(A) Deferred Stock Unit	1,257	$16.90	-	Direct
Oct 9, 2025	OSCR Oscar Health, Inc.	Award(A) Deferred Stock Unit	1,034	$20.54	-	Direct
Jul 10, 2025	OSCR Oscar Health, Inc.	Award(A) Deferred Stock Unit	1,368	$15.53	-	Direct
Jun 4, 2025	OSCR Oscar Health, Inc.	Award(A)	14,134	-	-	Direct
Apr 10, 2025	OSCR Oscar Health, Inc.	Award(A) Deferred Stock Unit	1,734	$12.25	-	Direct

1-9 of 9 transactions

About Plouffe David

Plouffe David (SEC CIK 0001844229) files insider reports with the SEC as Director of Oscar Health, Inc. (OSCR).

Signal8 holds 9 ownership filings by Plouffe David, all Form 4s, filed between Apr 14, 2025 and Oct 13, 2026. Those filings report 9 transactions, from Apr 10, 2025 to Oct 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Plouffe David's filings is in NEW YORK, NY.

Recent filings by Plouffe David

Oct 8, 2026: Grant or award of OSCR derivative securities (Form 4, code A).
Jul 9, 2026: Grant or award of OSCR derivative securities (Form 4, code A).
Jun 4, 2026: Grant or award of OSCR shares (Form 4, code A).
Apr 9, 2026: Grant or award of OSCR derivative securities (Form 4, code A).
Jan 8, 2026: Grant or award of OSCR derivative securities (Form 4, code A).

Other insiders filing for Oscar Health, Inc. (OSCR)

Sankaran Sid, Director
Gassen William, Director
WITTMAN VANESSA AMES, Director
Kushner Joshua, Co-Founder and Vice Chairman
Thrive Partners II GP, LLC, Director
Liang Janet, President, Oscar Insurance

How to read Form 4 transaction codes